Original filing (PDF)20250605141508NAL0020280992001

BOTANIX PHARMACEUTICALS INC

Name: BOTANIX PHARMACEUTICALS INC — BOTANIX PHARMACEUTICALS INC 401(K) P/S PLAN, Form 5500 (2024)
Creator: BOTANIX PHARMACEUTICALS INC

Form 5500-SF

FILING_RECEIVED

BOTANIX PHARMACEUTICALS INC 401(K) P/S PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$1.6M

Net assets (EOY)

$1.6M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for BOTANIX PHARMACEUTICALS INC.

Plan sponsor

Name

BOTANIX PHARMACEUTICALS INC

EIN

47-5167196

Address

150 N RADNOR CHESTER RD · SUITE A210 · WAYNE, PA · 19087

Phone

(445) 300-3403

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-06-05

Pension benefit codes

2E · Profit-sharing

3D · Pre-approved plan (master / prototype / VS)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2F · ERISA section 404(c)

2T · Default investment account (QDIA)

3H · Sponsor in controlled / affiliated group

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

BITTERROOT BIO, INC.

BITTERROOT BIO, INC. 401(K) PLAN

$1.6M · 30 participants

IQ BIOSCIENCES

IQ BIOSCIENCES 401(K) PLAN

$1.6M · 23 participants

IMMUNESENSOR THERAPEUTICS, INC.

IMMUNESENSOR THERAPEUTICS, INC. 401(K) PLAN

$1.6M · 9 participants

BRIDGENE BIOSCIENCES INC

BRIDGENE BIOSCIENCES INC 401(K) PLAN

$1.6M · 24 participants

KIMERA LABS INC

$1.6M · 34 participants